Factors | HROS (95%CI) | P Value | HRPFS (95%CI) | P Value | HRDMFS (95%CI) | P Value | HRLRFS (95%CI) | P Value |
---|---|---|---|---|---|---|---|---|
Pretreatment EBV DNA levela | 3.21 (1.58–6.53) | 0.001 | 3.11 (1.85–5.23) | < 0.001 | 2.55 (1.21–5.35) | 0.013 | 3.14 (1.51–6.54) | 0.002 |
Post-IC EBV DNA levelb | 2.50 (1.37–4.54) | 0.003 | 2.41 (1.52–3.80) | < 0.001 | 2.42 (1.26–4.65) | 0.008 | 2.25 (1.19–4.26) | 0.013 |
Pretreatment ADC valuea | 0.89 (0.47–1.70) | 0.727 | 1.42 (0.86–2.33) | 0.170 | 1.08 (0.54–2.15) | 0.838 | 1.83 (0.89–3.79) | 0.103 |
ΔADC%b | 0.44 (0.24–0.82) | 0.001 | 0.35 (0.22–0.56) | < 0.001 | 0.42 (0.21–0.81) | 0.01 | 0.26 (0.12–0.55) | < 0.001 |
Response phenotypesc | ||||||||
 Early response | reference | 0.001 | reference | < 0.001 | reference | 0.001 | reference | < 0.001 |
 Intermediate response | 5.50 (1.91–15.82) | 0.002 | 4.80 (2.33–9.88) | < 0.001 | 3.96 (1.47–10.66) | 0.006 | 4.93 (1.69–14.41) | 0.004 |
 No response | 8.52 (2.90–25.09) | < 0.001 | 8.83 (4.19–18.59) | < 0.001 | 7.03 (2.58–19.19) | < 0.001 | 10.50 (3.51–31.45) | < 0.001 |